Adrenocortical carcinoma and a sporadic MEN1 mutation in a 3-year-old girl: a case report

Childhood adrenocortical carcinoma (ACC) is a rare disease that is mostly linked to familial cancer syndrome. Although the prevalence of ACC is extremely low in children, it is clinically important to diagnose ACC early because age and tumor stage are closely related to prognosis. From this perspective, understanding the underlying genetics and possible symptoms of ACC is crucial in managing ACC with familial cancer syndromes. In this report, we present the case of a 3-year-old girl who initially presented with symptoms of precocious puberty and was later found to have ACC by imaging analysis. On genetic analysis, the patient was found to have a MEN1 gene mutation. MEN1 mutations are found in patients with multiple endocrine neoplasia type 1 (MEN1), usually precipitating multiple endocrine tumors, including pituitary adenoma, parathyroid hyperplasia, and adrenal tumors. Although MEN1 mutation is usually inherited in an autosomal dominant manner, neither of the patient’s parents had the same mutation, making hers a case of sporadic MEN1 mutation with initial presentation of ACC. The clinical course and further investigations of this patient are discussed in detail in this report.

[1]  J. Jung,et al.  Using Etomidate in a Two-month-old Infant with Cushing Syndrome due to Adrenocortical Carcinoma , 2020, Journal of clinical research in pediatric endocrinology.

[2]  M. Fragoso,et al.  Pediatric adrenocortical tumor - review and management update. , 2020, Current opinion in endocrinology, diabetes, and obesity.

[3]  C. Stratakis,et al.  Multiple Endocrine Neoplasia Type 1 (MEN1): An Update and the Significance of Early Genetic and Clinical Diagnosis , 2019, Front. Endocrinol..

[4]  P. Novotny,et al.  Adrenocortical Carcinoma in Children: A Clinicopathological Analysis of 41 Patients at the Mayo Clinic from 1950 to 2017 , 2018, Hormone Research in Paediatrics.

[5]  Kyungwon Oh,et al.  The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects , 2018, Korean journal of pediatrics.

[6]  Hae-sang Lee,et al.  Multiple Endocrine Neoplasia Type 1 Presenting as Hypoglycemia due to Insulinoma , 2016, Journal of Korean medical science.

[7]  Dae-Yeol Lee,et al.  Virilizing Adrenocortical Carcinoma Advancing to Central Precocious Puberty after Surgery , 2015, Korean journal of family medicine.

[8]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[9]  A. Tabarin,et al.  MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines. , 2015, The Journal of clinical endocrinology and metabolism.

[10]  E. Lalli,et al.  Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  K. Gow,et al.  Predictors of survival in pediatric adrenocortical carcinoma: a Surveillance, Epidemiology, and End Results (SEER) program study. , 2013, Journal of pediatric surgery.

[12]  S. Gruber,et al.  Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma. , 2013, The Journal of clinical endocrinology and metabolism.

[13]  S. Kropf,et al.  Systemic Treatment of Adrenocortical Carcinoma in Children: Data from the German GPOH-MET 97 Trial , 2012, Klinische Pädiatrie.

[14]  J. Bilezikian,et al.  Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). , 2012, The Journal of clinical endocrinology and metabolism.

[15]  M. Platten,et al.  Oncocytic adrenocortical neoplasms--a clinicopathologic study of 13 new cases emphasizing the importance of their recognition. , 2011, Human pathology.

[16]  H. Koh,et al.  Virilizing Adrenocortical Oncocytoma in a Child: A Case Report , 2010, Journal of Korean medical science.

[17]  R. Ribeiro,et al.  Familial predisposition to adrenocortical tumors: clinical and biological features and management strategies. , 2010, Best practice & research. Clinical endocrinology & metabolism.

[18]  J. Hwang,et al.  Virilizing adrenocortical carcinoma in a child with Turner syndrome and somatic TP53 gene mutation , 2010, European Journal of Pediatrics.

[19]  J. Hah Intensive chemotherapy with autologous PBSCT for advanced adrenocortical carcinoma in a child. , 2008, Journal of pediatric hematology/oncology.

[20]  C. Teinturier,et al.  Clinical and prognostic aspects of adrenocortical neoplasms in childhood. , 1999, Medical and pediatric oncology.